Evoqua Water Technologies to sell Memcor membrane business to DuPont

Evoqua Water Technologies has entered into a definitive agreement to sell its Memcor membrane business to DuPont Safety & Construction.

The divestment includes Memcor’s manufacturing site in Windsor, Australia, associated operations and intellectual property. DuPont will also acquire the workforce of the product line.

The transaction will add Evoqua ultrafiltration and membrane biofiltration technologies to DuPont’s portfolio of water purification and separation capabilities.

The portfolio includes ultrafiltration, reverse osmosis and ion exchange resins.

Evoqua Water Technologies CEO Ron Keating said: “This transaction is an excellent opportunity for Memcor and its employees to align with DuPont’s strength in membrane development and material science.

“Evoqua’s strategy is to source components that we can incorporate into innovative products, and integrated solutions and services, that align with our strengths.”

Through the sale, Evoqua intends to focus on core products and solutions. The company stated that it will continue to design and assemble membrane-based systems.

Memcor provides membranes and systems for municipal drinking water, wastewater reuse and wastewater applications.

The business supplies products for reverse osmosis pretreatment in industrial applications.

DuPont already supplies materials to Evoqua for ion exchange and reverse osmosis systems.

Evoqua said that the partnership will expand to include low-pressure membranes.

DuPont CEO Marc Doyle said: “Our strategic intent for the Water Solutions business is to have a robust portfolio of technologies so that our talented global organisation can leverage a broad range of solutions to solve our customers’ most pressing challenges.”

Subject to closing conditions and the receipt of and regulatory approvals, the completion of the sale is expected to take place by the end of this year.

DuPont Water Solutions global vice-president and general manager HP Nanda said: “The addition of Evoqua’s ultrafiltration portfolio opens DuPont Water Solutions to additional market spaces including membrane bioreactors, submerged and pressurized ultrafiltration systems bringing more choice and opportunity for customers.”

Last month, DuPont reached an agreement to acquire BASF’s ultrafiltration membrane business.